(Total Views: 407)
Posted On: 08/30/2021 3:30:40 PM
Post# of 1460
Up coming catalysts for AVXL.
1) Start of the Ph-2b/3 Fragile X trial.
2) Start of the Ph-2b/3 Parkinson's Dementia trial.
3) Start of the Ph-2b/3 Parkinson trial.
4) Start of the Frontotemporal Dementia (FTD) with first use of the A3-71 drug.
5) Revelation and trial start of the undisclosed rare disease indicated in the pipeline.
6) Publication in a peer review paper of the Parkinson's Dementia.
7) Readout of the Avatar Rett trial.
FDA possibly giving BTD for Rett.
9) FDA possibly giving AA for Rett.
10) Unexpected news on an unknown guidance from the FDA.
Any other possible news item is welcomed in a response.
(In no certain order as listed)
1) Start of the Ph-2b/3 Fragile X trial.
2) Start of the Ph-2b/3 Parkinson's Dementia trial.
3) Start of the Ph-2b/3 Parkinson trial.
4) Start of the Frontotemporal Dementia (FTD) with first use of the A3-71 drug.
5) Revelation and trial start of the undisclosed rare disease indicated in the pipeline.
6) Publication in a peer review paper of the Parkinson's Dementia.
7) Readout of the Avatar Rett trial.
FDA possibly giving BTD for Rett. 9) FDA possibly giving AA for Rett.
10) Unexpected news on an unknown guidance from the FDA.
Any other possible news item is welcomed in a response.
(In no certain order as listed)
(1)
(0)
